Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Aroa Biosurgery Ltd
ARXCurrent price
0.63 AUD
-0.035 AUD (-5.30%)
Last closed
0.68 AUD
Company
aroabio.com
ISIN
NZARXE0001S1
Sector
Healthcare
Industry
Medical Devices
Exchange
Australian Securities Exchange
Capitalization
228 505 889 AUD
Yield for 12 month
-16.67 %
1Y
3Y
5Y
10Y
15Y
ARX
Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; Myriad Morcells Fine that delivers a bolus of biologically important ECM proteins to help kick start and sustain healing; and OviTex and OviTex PRS, a reinforced bioscaffolds for use in hernia repair and abdominal wall reconstruction, as well as breast reconstruction. The company also offers Symphony, a combination cellular and tissue product, indicated for the regeneration of functional tissue in complex wounds. Aroa Biosurgery Limited was incorporated in 2007 and is headquartered in Auckland, New Zealand. Address: 64 Richard Pearse Drive, Auckland, New Zealand, 2022
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.43 AUDP/E ratio
–Dividend Yield
–Current Year
+65 255 518 AUD
Last Year
+60 452 296 AUD
Current Quarter
+17 386 864 AUD
Last Quarter
+17 578 157 AUD
Current Year
+55 706 137 AUD
Last Year
+51 021 890 AUD
Current Quarter
+15 035 582 AUD
Last Quarter
+15 201 008 AUD
Key Figures ARX
1 year
3 years
5 years
10 years
EBITDA
-7 440 698 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-5.86 %
PEG Ratio
–
Return On Equity TTM
-10.8 %
Wall Street Target Price
1.43 AUD
Revenue TTM
70 397 164 AUD
Book Value
0.28 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
9.3 %
Dividend Yield
–
Gross Profit TTM
30 887 054 AUD
Earnings per share
-0.031 AUD
Diluted Eps TTM
-0.031 AUD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-15.39 %
Dividend Analytics ARX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ARX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
2:1
Payout Ratio
–
Last Split Date
01.06.2018
Dividend Date
–
Stock Valuation ARX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
625
Enterprise Value Revenue
2.9907
Price Sales TTM
3.246
Enterprise Value EBITDA
-55.9407
Price Book MRQ
2.4157
Financials ARX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ARX
For 52 weeks
0.45 AUD
0.89 AUD
50 Day MA
0.55 AUD
Shares Short Prior Month
–
200 Day MA
0.57 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart